Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Mitochondrial dysfunction--a pharmacological target in Alzheimer's disease.

Eckert GP, Renner K, Eckert SH, Eckmann J, Hagl S, Abdel-Kader RM, Kurz C, Leuner K, Muller WE.

Mol Neurobiol. 2012 Aug;46(1):136-50. doi: 10.1007/s12035-012-8271-z. Epub 2012 May 3. Review.

PMID:
22552779
[PubMed - indexed for MEDLINE]
2.

Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes.

Leuner K, Schulz K, Schütt T, Pantel J, Prvulovic D, Rhein V, Savaskan E, Czech C, Eckert A, Müller WE.

Mol Neurobiol. 2012 Aug;46(1):194-204. doi: 10.1007/s12035-012-8300-y. Epub 2012 Jul 22. Review.

PMID:
22821186
[PubMed - indexed for MEDLINE]
3.

Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?

Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder JB, Eckert A, Müller WE.

Antioxid Redox Signal. 2007 Oct;9(10):1659-75. Review.

PMID:
17867931
[PubMed - indexed for MEDLINE]
4.

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.

Sas K, Robotka H, Toldi J, Vécsei L.

J Neurol Sci. 2007 Jun 15;257(1-2):221-39. Epub 2007 Apr 25. Review.

PMID:
17462670
[PubMed - indexed for MEDLINE]
5.

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

Dumont M, Lin MT, Beal MF.

J Alzheimers Dis. 2010;20 Suppl 2:S633-43. doi: 10.3233/JAD-2010-100507. Review.

PMID:
20421689
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease--therapeutic aspects.

Müller WE, Eckert A, Kurz C, Eckert GP, Leuner K.

Mol Neurobiol. 2010 Jun;41(2-3):159-71. doi: 10.1007/s12035-010-8141-5. Epub 2010 May 12. Review.

PMID:
20461558
[PubMed - indexed for MEDLINE]
7.

Mitochondrial alterations in Alzheimer's disease.

Baloyannis SJ.

J Alzheimers Dis. 2006 Jul;9(2):119-26. Review.

PMID:
16873959
[PubMed - indexed for MEDLINE]
8.

Mitochondria as a therapeutic target in Alzheimer's disease and diabetes.

Moreira PI, Cardoso SM, Pereira CM, Santos MS, Oliveira CR.

CNS Neurol Disord Drug Targets. 2009 Dec;8(6):492-511. Review.

PMID:
19702564
[PubMed - indexed for MEDLINE]
9.

Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease.

Onyango IG, Khan SM.

Curr Alzheimer Res. 2006 Sep;3(4):339-49. Review.

PMID:
17017864
[PubMed - indexed for MEDLINE]
10.

Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.

de la Monte SM, Wands JR.

J Alzheimers Dis. 2006 Jul;9(2):167-81.

PMID:
16873964
[PubMed - indexed for MEDLINE]
11.

Mitochondrial involvement in Alzheimer's disease.

Bonilla E, Tanji K, Hirano M, Vu TH, DiMauro S, Schon EA.

Biochim Biophys Acta. 1999 Feb 9;1410(2):171-82. Review.

PMID:
10076025
[PubMed - indexed for MEDLINE]
Free Article
12.

Catecholamine-induced cardiac mitochondrial dysfunction and mPTP opening: protective effect of curcumin.

Izem-Meziane M, Djerdjouri B, Rimbaud S, Caffin F, Fortin D, Garnier A, Veksler V, Joubert F, Ventura-Clapier R.

Am J Physiol Heart Circ Physiol. 2012 Feb 1;302(3):H665-74. doi: 10.1152/ajpheart.00467.2011. Epub 2011 Nov 18.

PMID:
22101527
[PubMed - indexed for MEDLINE]
Free Article
13.

Mitochondria: a therapeutic target in neurodegeneration.

Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA.

Biochim Biophys Acta. 2010 Jan;1802(1):212-20. doi: 10.1016/j.bbadis.2009.10.007. Epub 2009 Oct 21. Review.

PMID:
19853657
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The key role of mitochondria in Alzheimer's disease.

Moreira PI, Cardoso SM, Santos MS, Oliveira CR.

J Alzheimers Dis. 2006 Jul;9(2):101-10. Review.

PMID:
16873957
[PubMed - indexed for MEDLINE]
15.

Are mitochondria critical in the pathogenesis of Alzheimer's disease?

Reddy PH, Beal MF.

Brain Res Brain Res Rev. 2005 Nov;49(3):618-32. Epub 2005 Apr 19. Review.

PMID:
16269322
[PubMed - indexed for MEDLINE]
16.

Mitochondrial dysfunction and Alzheimer's disease.

Maruszak A, Żekanowski C.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):320-30. doi: 10.1016/j.pnpbp.2010.07.004. Epub 2010 Jul 16. Review.

PMID:
20624441
[PubMed - indexed for MEDLINE]
17.

Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.

Verri M, Pastoris O, Dossena M, Aquilani R, Guerriero F, Cuzzoni G, Venturini L, Ricevuti G, Bongiorno AI.

Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):345-53. Review.

PMID:
22697066
[PubMed - indexed for MEDLINE]
18.

Mitochondria as a pharmacological target: magnum overview.

Olszewska A, Szewczyk A.

IUBMB Life. 2013 Mar;65(3):273-81. doi: 10.1002/iub.1147. Review.

PMID:
23441041
[PubMed - indexed for MEDLINE]
19.

Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.

Yao J, Brinton RD.

Curr Pharm Des. 2011;17(31):3474-9.

PMID:
21902662
[PubMed - indexed for MEDLINE]
20.

Role of mitochondrial amyloid-beta in Alzheimer's disease.

Chen JX, Yan SS.

J Alzheimers Dis. 2010;20 Suppl 2:S569-78. doi: 10.3233/JAD-2010-100357. Review.

PMID:
20463403
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk